Literature DB >> 14580374

IL-1 beta is a better inducer of apoptosis in human fetal membranes than IL-6.

S J Fortunato1, R Menon.   

Abstract

The objective of this study was to compare two of the inflammatory cytokines (IL-1 and IL-6) elevated in both preterm labour and preterm premature rupture of the membranes (pPROM), with respect to their ability to induce fetal membrane apoptosis. Fetal membranes collected from women at term were placed in an organ explant system and stimulated with recombinant human IL-1 beta and IL-6. The expression patterns of pro-apoptotic genes (Fas, FasL, TRADD, FADD) and caspases 2, 3, 8, 9 were studied using PCR. Caspase activity and DNA fragmentation were studied using substrate assays and TUNEL respectively. Caspase 8 and 9 expressions were induced in IL-1 beta and IL-6 treated amniochorion. Caspase 2 expression was seen only in IL-1 beta stimulated tissues. When compared to control, IL-1 beta increased caspase 2, 3, 8 and 9 activities, whereas IL-6 treated membranes did not exhibit a significant change. DNA fragmentation was seen in greater numbers after IL-1 beta treatment than after IL-6 treatment. This study demonstrates that IL-1 beta is a better inducer of apoptosis in normal human fetal membranes than IL-6.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14580374     DOI: 10.1016/s0143-4004(03)00160-7

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  16 in total

1.  A proposed bio-panel to predict risk for spontaneous preterm birth among African American women.

Authors:  Shannon L Gillespie; Lisa M Christian; Jeremy L Neal
Journal:  Med Hypotheses       Date:  2015-07-31       Impact factor: 1.538

Review 2.  Preterm prelabor rupture of the membranes: A disease of the fetal membranes.

Authors:  Ramkumar Menon; Lauren S Richardson
Journal:  Semin Perinatol       Date:  2017-08-12       Impact factor: 3.300

3.  DIDS protects against neuronal injury by blocking Toll-like receptor 2 activated-mechanisms.

Authors:  Hang Yao; Hady Felfly; Juan Wang; Dan Zhou; Gabriel G Haddad
Journal:  J Neurochem       Date:  2008-12-10       Impact factor: 5.372

4.  Bacterial modulation of human fetal membrane Toll-like receptor expression.

Authors:  Vikki M Abrahams; Julie A Potter; Geeta Bhat; Morgan R Peltier; George Saade; Ramkumar Menon
Journal:  Am J Reprod Immunol       Date:  2012-09-11       Impact factor: 3.886

5.  Human fetal membranes generate distinct cytokine profiles in response to bacterial Toll-like receptor and nod-like receptor agonists.

Authors:  Mai Hoang; Julie A Potter; Stefan M Gysler; Christina S Han; Seth Guller; Errol R Norwitz; Vikki M Abrahams
Journal:  Biol Reprod       Date:  2014-02-27       Impact factor: 4.285

Review 6.  Possible roles of proinflammatory and chemoattractive cytokines produced by human fetal membrane cells in the pathology of adverse pregnancy outcomes associated with influenza virus infection.

Authors:  Noboru Uchide; Kunio Ohyama; Toshio Bessho; Makoto Takeichi; Hiroo Toyoda
Journal:  Mediators Inflamm       Date:  2012-07-31       Impact factor: 4.711

7.  The Effect of Progestins on Tumor Necrosis Factor α-Induced Matrix Metalloproteinase-9 Activity and Gene Expression in Human Primary Amnion and Chorion Cells In Vitro.

Authors:  Terrence K Allen; Liping Feng; Matthew Nazzal; Chad A Grotegut; Irina A Buhimschi; Amy P Murtha
Journal:  Anesth Analg       Date:  2015-05       Impact factor: 6.627

8.  Soluble tumor necrosis factor receptor mediates cell proliferation on lipopolysaccharide-stimulated cultured human decidual stromal cells.

Authors:  Xue-Wen Yu; Xin-Wen Zhang; Xu Li
Journal:  Int J Mol Sci       Date:  2009-05-04       Impact factor: 6.208

9.  Interleukin-1 modulation of human placental trophoblast proliferation.

Authors:  Athip Nilkaeo; Suthinee Bhuvanath
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

10.  Bioprocessing of cryopreservation for large-scale banking of human pluripotent stem cells.

Authors:  Yan Li; Teng Ma
Journal:  Biores Open Access       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.